Efficacy and Safety Results of Different Ablation Technologies for Persistent Atrial Fibrillation Treatment
Ablation Technologies in Persistent Atrial Fibrillation Treatment
DOI:
https://doi.org/10.1532/hsf.4853Keywords:
atria fibrillation, cryoballoon, catheter ablationAbstract
Introduction: Pulmonary vein isolation is the primary goal in treating patients with paroxysmal atrial fibrillation using catheter ablation. This study's purpose is a comparative assessment of the efficacy and safety of two strategies for catheter treatment in patients with persistent atrial fibrillation.
Patients and methods: The study included 127 patients with persistent atrial fibrillation during the last six months before inclusion in the study. The average follow-up period was 24 months.
Results: The primary efficacy endpoint (death, cerebrovascular event, or serious complications associated with treatment) occurred in 15 patients in the cryoballoon ablation group and 14 patients in the radiofrequency ablation group. The Kaplan-Meier survival estimates were 30% and 28%, and the risk ratio 0.96 and 95% of the confidence interval.
Conclusions: The treatment in patients with persistent atria fibrillation, using catheter ablation with contact force control catheter treatment with the pulmonary vein isolation, was more efficient.
References
Ang R, Hunter RJ, Lim WY, Opel A, Ullah W, Providencia R, et al. 2018. Long term outcome and pulmonary vein reconnection of patients undergoing cryoablation and/or radiofrequency ablation: results from the Cryo Versus RF trial. J Atr Fibrillation. 11(3).
Aryana A, Singh SM, Mugnai G, de Asmundis C, Kowalski M, Pujara DK, et al. 2016. Pulmonary vein reconnection following catheter ablation of atrium fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: results of a multicenter analysis. J Interv Card Electrophysiol. 47:341–348.
Baimbetov A, Bizhanov R, Bairamov B. 2018. Immediate results of pulmonary veins cryoablation in patients with atrium fibrillation. Gefasmedizin. 12(1):64–71.
Baimbetov A, Kuzhukeev M, Bizhanov R, Yakupova I, Bozshagulov T, Kuzhukeyev M, Ismailova G. 2018. Atrium fibrillation ablation using second generation cryoballoon. Cryoballoon ablation. New Armenian Med J. 12(1):64-71.
Baimbetov A, Rzaev F, Bizhanov R, Bairamov BA, Yakupova IA. 2018. New trends in the interventional arrhythmology: a 2-center experience in atrium fibrillation cryoablation. J Arrhythmol. 8:71–76.
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrium fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 33:171–257.
Camm AJ, Lip GY, De Caterina R, De Caterina R, Savelieva I, Atar D, et al. 2012. ESC Committee for Practice Guidelines (CPG). 2012 Focused update of the ESC Guidelines for the management of atrium fibrillation: an update of the 2010 ESC Guidelines for the management of atrium fibrillation: developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 33:2719–2747.
Chen Y, Lu Zh, Xiang Y, Hou JW, Wang Q, Lin H, Li YG. 2017. Cryoablation vs. radiofrequency ablation for treatment of paroxysmal atrium fibrillation: A systematic review and meta-analysis. EP Europace. Jan 8.
Chun KRJ, Perrotta L, Bordignon S, Khalil J, Dugo D, Konstantinou A, et al. 2017. Complications in catheter ablation of atrium fibrillation in 3,000 consecutive procedures: balloon versus radiofrequency current ablation. JACC. 3(154):61.
De Lavallaz J, Clerc O, Pudenz C, Illigens B, Kühne M. 2019. Sex-specific efficacy and safety of cryoballoon versus radiofrequency ablation for atrium fibrillation: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 19:77–83.
Evonich R, Nori D, Haines D. 2007. A randomized trial comparing effects of radiofrequency and cryoablation on the structural integrity of esophageal tissue. J Interv Cardiovasc Electrophysiol. 19:77–83.
Haissaguerre M, Jais P, Shah D, Garrigue S, Takahashi A, Lavergne T, et al. 2000. Electrophysiological endpoint for catheter ablation of AF initiated from multiple pulmonary venous foci. Circulation. 101(12):1409-1417.
Heeger CH, Wissner E, Knöll M, Knoop B, Reissmann B, Mathew S, et al. 2017. Three-year clinical outcome after 2nd-generation cryoballoon-based pulmonary vein isolation for the treatment of paroxysmal and persistent atrium fibrillation: a 2-center experience. Circ J. 81(974):80.
Kuck KH, Albenque JP, Chun JK, Fürnkranz A, Busch M, Elvan A, et al. 2019. Repeat ablation for atrium fibrillation recurrence post cryoablation or radiofrequency ablation in the FIRE AND ICE trial. Circ Arrhythm Electrophysiol. 12(6):e007247.
Kuck KH, Brugada J, Furnkranz A, Metzner A, Ouyang F, Chun KJ, et al. 2016. Cryoballoon or radiofrequency ablation for paroxysmal atrium fibrillation. N Engl J Med. 374:2235–2245.
Kuck KH, Fürnkranz A, Chun KR, Metzner A, Ouyang F, Schlüter M, et al. 2016. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrium fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 37(38):2858–2865.
Luik A, Radzewitz A, Kieser M, Walter M, Bramlage P, Hörmann P, et al. 2015. Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrium Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study. Circulation. 132(14):1311:9.
Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. 2010. Long-term results of catheter ablation in paroxysmal atrium fibrillation: lessons from a 5-year follow-up. Circulation. 122:2368–2377.
Packer D, Kowal R, Wheelan K, Irwin JM, Champagne J, Guerra PG, et al. 2013. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrium Fibrillation First Results of the North American Arctic Front (STOP AF) Pivotal Trial. JACC. 16-61(1713):23.
Pokushalov E, Romanov A, Artyomenko S, Baranova V, Losik D, Bairamova S, et al. 2013. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrium fibrillation. J Cardiovasc Electrophysiol. 24:274–279.
Revishvili A, Rzaev F, Sopov O, Labazanova AL. 2012. Long-term results of interventional treatment of atrium fibrillation. J Arrhythmology. 68:5–13.
Su W, Aryana A, Passman R, Singh G, Hokanson R, Kowalski M, et al. 2018. Cryoballoon best practices II: practical guide to procedural monitoring and dosing during atrium fibrillation ablation from the perspective of experienced users. Heart Rhythm. 15: 1348–1355.
Tuleutayev RB, Abzaliyev KB, Baimbetov AK, Urazbecov DO. 2017. Method of thoracoscopic radiofrequency ablation of atrial fibrillation for improving visualization and facilitation in atrial fibrillation. Patent for invention. Sep 33672.
Verma A, Jiang C, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. 2015. Approaches to catheter ablation for persistent atrium fibrillation. N Engl J Med. 372:1812-1822.
Wechselberger S, Kronborg M, Huo Y, Piorkowski J, Neudeck S, Päßler E, et al. 2018. Continuous monitoring after atrial fibrillation ablation: the LINQ AF study. EP Europace. 20(FI_3):f312-f320.
